Related references
Note: Only part of the references are listed.Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells
Victor M. Campa et al.
BIOLOGY DIRECT (2011)
Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3α/β dependent mechanism
Juliet C. Russell et al.
CELLULAR SIGNALLING (2011)
The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases
Amar S. et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
Miguel Medina et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
Yingwei Mao et al.
CELL (2009)
Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment
Tina Gjoni et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice
Sawako Arai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
A β-arrestin 2 signaling complex mediates lithium action on Behavior
Jean-Martin Beaulieu et al.
CELL (2008)
Involvement of Pallidotegmental Neurons in Methamphetamine- and MK-801-Induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist Baclofen
Sawako Arai et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
Bernard Masri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reduced cortical inhibition in first-episode schizophrenia
T. Wobrock et al.
SCHIZOPHRENIA RESEARCH (2008)
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Xiaohua Li et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
The Akt-GSK-3 signaling cascade in the actions of doparnine
Jean-Martin Beaulieu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Targeting the dopamine D2 receptor in schizophrenia
Philip Seeman
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways
Eleonore Beurel et al.
PROGRESS IN NEUROBIOLOGY (2006)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
H Alimohamad et al.
BIOLOGICAL PSYCHIATRY (2005)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?
PJ Tyson et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2004)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
P De Sarno et al.
NEUROPHARMACOLOGY (2002)
Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain
HB Yao et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2002)
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation
ZJ Daskalakis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain
K Mizukami et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
GSK3 takes centre stage more than 20 years after its discovery
S Frame et al.
BIOCHEMICAL JOURNAL (2001)
Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence
LL Demchyshyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structure and function of dopamine receptors
D Vallone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
Share Paper
